All patients. Distribution of MUC-1/CA 15-3 concentrations (U/mL)... | Download Table
CA 15.3 Test: Procedure, Purpose, Results, Normal range, Cost, Price, Online booking
CA 15-3 and survival according to disease extent | Download Table
Number of Patients with Serum CEA and CA 15-3 Levels Higher Than the... | Download Table
AKCIJA TUMOR MARKER CA 15-3
Diagnostic value of HER-2/neu and CA15-3 at 85th percentile | Download Table
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect
CA 15-3: Reference Range, Interpretation, Collection and Panels
Plasma levels of tested parameters and CA 15-3 in patients with breast... | Download Table
Relationship between CA 15-3 serum levels and size of the tumor in the... | Download Scientific Diagram
Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer
Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes - ScienceDirect
Anamnestic data and average values of CEA and CA 15-3 markers in... | Download Table
CA 15-3 Antigen - an overview | ScienceDirect Topics
PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar
Plasma levels of tested cytokines and CA 15-3 in patients with breast... | Download Table
CA 15-3 Antigen - an overview | ScienceDirect Topics
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text
CA 15-3 Antigen - an overview | ScienceDirect Topics
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
An individual reference limit of the serum CEA-TPA-CA 15-3 tumor marke | CMAR
Premium Photo | Ca 15 3 rapid test device a tumor marker for breast cancer diagnosis
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
Observed changes in CA 15-3 levels in patients with de novo disease... | Download Scientific Diagram